Boston, MA
TCT: Boston Scientific’s drug-coated coronary balloon outperforms typical uncoated angioplasty
A clinical study from Boston Scientific showed that a drug-coated balloon small enough to reach and reopen the heart’s coronary arteries could outperform traditional drugless angioplasty procedures | The company described the trial as the first in the U.S. to examine the use of a drug-coated balloon to clear coronary stents that have become obstructed over time.